PharmAla signs distribution agreement for its MDMA drug in the U.S.

Green Market Report
By Debra BorchardtMar 24, 2025, 11:04 am68 pts
PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTC: MDXXF) announced that it has contracted with a third-party logistics company specializing in pharmaceutical products to act as its US clinical trial distribution partner. PharmAla makes novel MDXX class molecules including its LaNeo MDMA. However, the name of…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Verano secures $12M loan from Rainbow Realty Group 69

Struggling marijuana MSO Schwazze defaults on restructured debt 69

Virginia GOP Governor Vetoes Recreational Marijuana Sales Legalization Plan 69

Shop 40% off at Story Cannabis this 420 68

Cannabis MSO Verano Holdings secures $12 million loan 68

Story Cannabis: Serving medical & non-medical cannabis customers in Ohio 68

Virginia: Governor Vetoes Adult-Use Marijuana Retail, Guts Medical Access Legislation 66

Make 420 mega with 30% off from Grön 65

About NewsBudz

NewsBudz is a marijuana and medical cannabis news app. The site delivers a daily feed of the latest cannabis news. We aggregate over 30 of the web's best sources for news about marijuana, hemp and legalization to keep you informed.

Stay on top of the latest news headlines, trends and developments worldwide around recreational and medical marijuana. Sit back and relax, while you read learn and share. On the web or your mobile device, NewsBudz is your cannabis news stream.